Direct-pay models eliminate prior authorization paperwork and the frustration of unexpected coverage denials
Huberman emphasizes that while peptides show potential, they should be approached cautiously and used under professional supervision
The more intriguing possibility is that the drug does something beyond shrinking the patient
The SmPC notes that the human relevance of rodent C-cell tumours is unknown and advises that patients should report symptoms such as a neck mass, dysphagia (difficulty swallowing), dyspnoea (breathing difficulty), or persistent hoarseness
B12 can hurt when injected to push the plunger slowly
Join Circana for an upcoming webinar, The Ripple Effect of GLP-1s, Today and In the Future, on Wednesday, Jan